{"id":"W2897495391","doi":"10.1161/circulationaha.118.035418","title":"Outcomes Associated With Apixaban Use in Patients With End-Stage Kidney Disease and Atrial Fibrillation in the United States","year":2018,"lang":"en","type":"article","venue":"Circulation","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":487,"is_retracted":false,"has_abstract":true,"ca_institutions":"The Quebec Population Health Research Network","funders":"U.S. National Library of Medicine","keywords":"Apixaban; Medicine; Rivaroxaban; Dabigatran; Warfarin; Atrial fibrillation; Internal medicine; Stroke (engine); Dialysis; Hazard ratio; Kidney disease; End stage renal disease; Population; Proportional hazards model; Retrospective cohort study; Intensive care medicine; Disease; Confidence interval","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008995055,0.0002846213,0.0003643175,0.001076478,0.0004145949,0.0006684529,0.0003779078,0.000421556,0.001008561],"category_scores_gemma":[0.002473989,0.0002389467,0.0005244716,0.001829041,0.0003653825,0.0005630763,0.0006806841,0.0006947301,0.0001299517],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005649053,"about_ca_system_score_gemma":0.0005612607,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.007614238,"about_ca_topic_score_gemma":0.01009796,"domain_scores_codex":[0.999113,0.0002290921,0.0001600346,0.0001923608,0.0001777846,0.0001276506],"domain_scores_gemma":[0.9962536,0.0003431092,0.002470552,0.0001355433,0.0002702937,0.0005268728],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00003931243,0.00001440014,0.999506,0.000003846332,0.00002983471,0.00002541963,0.00001339884,0.00001778337,0.00002227731,0.000006066643,0.00005347903,0.0002681956],"study_design_scores_gemma":[0.000005835849,0.00003484192,0.9995158,0.000005248502,0.00001994246,0.0001461214,0.00006834316,0.0001025744,0.0000147176,0.00001423364,0.00007003724,0.000002244119],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9984725,0.0004417492,0.00005958291,0.0000923487,0.000008637725,0.00000861303,0.0006297136,0.000003201202,0.000283607],"genre_scores_gemma":[0.9991297,0.0001443365,0.00004576678,0.0000420422,0.00001562414,0.000008501294,0.0005720979,8.471782e-7,0.00004114427],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007614238,"threshold_uncertainty_score":0.01513982,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03995022917469284,"score_gpt":0.2866351348459032,"score_spread":0.2466849056712103,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}